The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Jin Ho Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences and Technology, College of Natural Sciences, College of Medicine, Institute of Systems Biology & Life Science Informati…. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Carbamates. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease (PD) is a progressive neurodegenerative disease that causes motor abnormalities such as tremors, rigidity, and posture imbalance. The loss of dopaminergic neurons and Lewy bodies containing the aggregation of α-synuclein are the main neuropathological features of PD. Rotenone, a widely used pesticide and mitochondrial complex I inhibitor, induces dopaminergic neuronal death and is used to model PD in rodents. We previously reported that JBPOS0101, a phenyl carbamate compound, attenuates amyloid β accumulation and memory impairment in the 5xFAD mouse model of Alzheimer's disease. In this study, we investigated the effect of JBPOS0101 and its derivative, JBPOS0607, in rotenone-administered mice as a PD model. Both drugs significantly attenuated the loss of dopaminergic neurons induced by rotenone in mice. Furthermore, the rotenone-induced accumulation of phosphorylated α-synuclein in dopaminergic neurons was also attenuated by the drugs. Additionally, both drugs alleviated rotenone-induced activation of astrocytes and microglia compared to the group treated with rotenone alone. These results indicate that the phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neurodegeneration in mice. Both compounds preserved nigral dopaminergic neurons and attenuated alpha-synuclein phosphorylation, glial activation, and pro-inflammatory cytokine levels in the striatum, and JBPOS0607 was also effective in restoring the anti-inflammatory cytokine IL-10, striatal dopamine levels, and motor performance, supporting the therapeutic potential of phenyl carbamates in Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences and Technology, College of Natural Sciences, College of Medicine, Institute of Systems Biology & Life Science Informatics, Chonnam National University, Gwangju, Republic of Korea.
- Bio-Pharm Solutions Co. Ltd, Suwon, Gyeonggi-Do, Republic of Korea.
- School of Biological Sciences and Technology, College of Natural Sciences, College of Medicine, Institute of Systems Biology & Life Science Informatics, Chonnam National University, Gwangju, Republic of Korea. Electroni…
Zitieren
APA
Lee, J. H., Jeong, J. H., Mun, B. R., Jang, J. K., Choi, Y. M., Baek, J. H., & Choi, W. S. (2026). The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice. Brain Research. https://doi.org/10.1016/j.brainres.2026.150555
Vancouver
Lee JH, Jeong JH, Mun BR, Jang JK, Choi YM, Baek JH, et al. The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice. Brain Research. 2026. doi:10.1016/j.brainres.2026.150555
BibTeX
@article{Lee2026,
author = {Lee, Jin Ho and Jeong, Ji Hoon and Mun, Bo-Ram and Jang, Ju Kyong and Choi, Yong Moon and Baek, Jin-Ho and Choi, Won-Seok},
title = {The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150555}
}
EUVIMED